about
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regressionUrinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study.Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.Involvement of hypoxia-inducible transcription factors in polycystic kidney disease.Physiology of the Renal Interstitium.Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendationsIs hemojuvelin a possible new player in iron metabolism in hemodialysis patients?Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease.Autosomal Dominant Polycystic Disease is Associated with Depressed Levels of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off?Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.Metabolic abnormalities in autosomal dominant polycystic kidney disease.Intermittent hypoxia in childhood: the harmful consequences versus potential benefits of therapeutic usesHypertension in autosomal-dominant polycystic kidney disease (ADPKD).HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.Polycythaemia treated with nephrectomyDeterminants of renal tissue hypoxia in a rat model of polycystic kidney disease.
P2860
Q33730091-66344F80-00AC-416E-AA46-6A6BB6F10047Q34398335-F17AF6A3-DC6B-428E-B74E-EA9E384BE54DQ34534923-8768BCC9-AA09-4529-A89C-4307D3E07FA1Q35781329-80E3E170-B3F3-41CA-A69A-32B8C9DAAACFQ36123584-42FB34FE-2366-4B32-9B8B-D841D3606551Q36285948-062B1D26-1918-4D1B-AA4A-98C1C597D374Q36434771-CEC7584A-9800-42A1-B3C0-A9E8ADFFF304Q37262853-435B6CA5-5B5C-4E06-AEEB-BF9563FAD7D0Q37324586-1FC81ACE-ED2A-4C35-91CF-F8ADC5E96381Q37510916-79BBE471-2C9C-43C6-AECB-F12E236DED42Q37604709-728E5D26-535C-40F0-B19F-BFD9E3F2FA2EQ38192854-5006A34E-0CD6-44F1-9BEA-8BF77A628490Q38515370-0CEB0B10-4922-4B35-8DD4-3FE11CEA5BD2Q38524722-9657FCD3-2805-4254-9B18-655B43D193F5Q38666170-96BDEDEF-7341-4BD6-ACE1-C3A0A5576C35Q40329652-0D4D15DB-4F53-4BF4-A96B-367A903F9B7CQ47816023-B78F937C-99A1-469A-9771-938EF2A6FAA7
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Erythropoietin in polycystic kidneys
@ast
Erythropoietin in polycystic kidneys
@en
type
label
Erythropoietin in polycystic kidneys
@ast
Erythropoietin in polycystic kidneys
@en
prefLabel
Erythropoietin in polycystic kidneys
@ast
Erythropoietin in polycystic kidneys
@en
P2093
P2860
P356
P1476
Erythropoietin in polycystic kidneys
@en
P2093
Brunkhorst R
Buchholz B
Eckardt KU
Lonnemann G
Möllmann M
P2860
P304
P356
10.1172/JCI114280
P407
P577
1989-10-01T00:00:00Z